Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Victor

Showing results (241-250 of 262) with videos related to

Pageof 27
Sort By:
Psychological Medicine|May 12, 2026
Commonalities in frailty and psychopathology predict chronotype across severe mental disorders from a comorbidity perspectiveJoan Vicent Sánchez-Ortí, Patricia Correa-Ghisays, Vicent Balanzá-Martínez, et al.
Frontiers in Neurology|June 20, 2022
Immune-Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up StudyMarta Garés-Caballer, Joan Vicent Sánchez-Ortí, Patricia Correa-Ghisays, et al.
Bipolar Disorders|November 30, 2013
Could comorbid bipolar disorder account for a significant share of executive function deficits in adults with attention-deficit hyperactivity disorder?Katiane L Silva, Diego L Rovaris, Paula O Guimarães-da-Silva, et al.
Brain, Behavior, & Immunity - Health|March 6, 2025
Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disordersJoan Vicent Sánchez-Ortí, Patricia Correa-Ghisays, Vicent Balanzá-Martínez, et al.
Journal of Clinical Psychology|September 4, 2020
Feasibility trial of the dialectical behavior therapy skills training group as add-on treatment for adults with attention-deficit/hyperactivity disorderGuilherme R Moritz, Leandro T Pizutti, Ana C M Cancian, et al.
Journal of Attention Disorders|February 21, 2012
Cognitive deficits in adults with ADHD go beyond comorbidity effectsKatiane L Silva, Paula O Guimarães-da-Silva, Eugenio H Grevet, et al.
Journal of Clinical Psychopharmacology|March 1, 2014
Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic studyMarcelo M Victor, Diego L Rovaris, Carlos A I Salgado, et al.
CNS Spectrums|July 14, 2012
The role of a lifetime history of oppositional defiant and conduct disorders in adults with ADHD: implications for clinical practiceEduardo S Vitola, Carlos A I Salgado, Katiane L Silva, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 20, 2008
The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continentsGuilherme Polanczyk, Stephen V Faraone, Claiton H D Bau, et al.
Redox Biology|June 28, 2020
Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancerMaría A Rodríguez-Hernández, P de la Cruz-Ojeda, Mª José López-Grueso, et al.
Pageof 27

Showing results (241-250 of 262) with videos related to

Sort By:
Pageof 27
Psychological Medicine|May 12, 2026
Commonalities in frailty and psychopathology predict chronotype across severe mental disorders from a comorbidity perspectiveJoan Vicent Sánchez-Ortí, Patricia Correa-Ghisays, Vicent Balanzá-Martínez, et al.
Frontiers in Neurology|June 20, 2022
Immune-Inflammatory Biomarkers Predict Cognition and Social Functioning in Patients With Type 2 Diabetes Mellitus, Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: A 1-Year Follow-Up StudyMarta Garés-Caballer, Joan Vicent Sánchez-Ortí, Patricia Correa-Ghisays, et al.
Bipolar Disorders|November 30, 2013
Could comorbid bipolar disorder account for a significant share of executive function deficits in adults with attention-deficit hyperactivity disorder?Katiane L Silva, Diego L Rovaris, Paula O Guimarães-da-Silva, et al.
Brain, Behavior, & Immunity - Health|March 6, 2025
Specific immune-inflammatory profiles and neurocognitive deficits predict illness trajectories in people with type 2 diabetes mellitus or psychiatric disordersJoan Vicent Sánchez-Ortí, Patricia Correa-Ghisays, Vicent Balanzá-Martínez, et al.
Journal of Clinical Psychology|September 4, 2020
Feasibility trial of the dialectical behavior therapy skills training group as add-on treatment for adults with attention-deficit/hyperactivity disorderGuilherme R Moritz, Leandro T Pizutti, Ana C M Cancian, et al.
Journal of Attention Disorders|February 21, 2012
Cognitive deficits in adults with ADHD go beyond comorbidity effectsKatiane L Silva, Paula O Guimarães-da-Silva, Eugenio H Grevet, et al.
Journal of Clinical Psychopharmacology|March 1, 2014
Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic studyMarcelo M Victor, Diego L Rovaris, Carlos A I Salgado, et al.
CNS Spectrums|July 14, 2012
The role of a lifetime history of oppositional defiant and conduct disorders in adults with ADHD: implications for clinical practiceEduardo S Vitola, Carlos A I Salgado, Katiane L Silva, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 20, 2008
The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continentsGuilherme Polanczyk, Stephen V Faraone, Claiton H D Bau, et al.
Redox Biology|June 28, 2020
Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancerMaría A Rodríguez-Hernández, P de la Cruz-Ojeda, Mª José López-Grueso, et al.
Pageof 27